Week in Review
Dendreon Corp. raised $125 million by monetizing its share of royalties on Victrelis (boceprevir).
EMBL Ventures GmbH closed a $53.5 million fund for German life science companies.
Forbion Capital Partners closed its second FCF 1 Co-Investment Fund at about $50 million.
Gilead Sciences Inc. priced $3.7 billion worth of senior unsecured notes in a public offering.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter